News

February 14, 2017

We are proud to announce that we have been invited by the Israel Innovation Authority to participate as part of the Israel Pavilion, at the Bio International Convention, San Diego, CA, June 19-22. This gives us a great opportunity to present our breakthrough Alpha DaRT...

January 31, 2017

Alpha TAU Medical fully supports World Cancer Day 2017 (Saturday, February 4), and is inspired by its efforts to unite the world against this disease; to target misinformation, to raise awareness, and to reduce stigma.

Under the campaign theme “We can. I can.” World Can...

January 19, 2017

Alpha Tau Medical has received IRB approval from IRST (Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori), in Italy for clinical trials with its Alpha DaRT (Diffusing Alpha–emitters Radiation Therapy) technology for the treatment of Squamous Cell Carcin...

January 12, 2017

Alpha Tau Medical has initiated its first clinical trials with its Alpha DaRT (Diffusing Alpha–emitters Radiation Therapy) technology for the treatment of Squamous Cell Carcinoma (SCC) in Head, Neck and Skin at the Rabin Medical Center, Petah Tikva outside Tel Aviv.
Th...

Please reload

Categories
Please reload

Sign up
Featured Posts

Breakthrough Cancer Therapy Developer, Alpha Tau, Awarded ISO 13485 Certificate for Quality Management of Medical Devices

April 11, 2019

1/5
Please reload

Archive
Please reload

Follow Us
  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon
  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon

CONTACT US

Are you looking to participate in clinical trials?

Take our self-assessment test to find potentially suitable studies.

For other inquiries, please visit our contact page.